IDiyas

For the Inventor, By the Inventor

Roselle Park, NJ, United States of America

Sergei Kolotuchin

USPTO Granted Patents = 8 


Average Co-Inventor Count = 11.5

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Roselle Park, NJ (US) (2008 - 2023)
  • Princeton, NJ (US) (2022 - 2024)

Company Filing History:

goldMedal8 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
silverMedal1 out of 2,076 
 
Janssen Pharmaceutica Nv
 patents
where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):
1. 12378246 - Synthetic options towards the manufacture of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl} - 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one (2025-08-05),
2. 11919863 - Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation (2024-03-05),
3. 11649226 - Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl- D3)pyridazine-3-carboxamide (2023-05-16),
4. 11236048 - Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation (2022-02-01),
5. 10899745 - Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide (2021-01-26),
6. 8278462 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof (2012-10-02),
7. 7705033 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof (2010-04-27),
8. 7420079 - Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof (2008-09-02),

Title: Innovator Spotlight: Sergei Kolotuchin

Introduction

Sergei Kolotuchin, a talented inventor based in Roselle Park, NJ, has made significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Kolotuchin's work focuses on developing innovative compounds that address critical health issues.

Latest Patents

Among Kolotuchin's notable patents are methods for preparing substituted quinolinylcyclohexylpropanamide compounds. This invention demonstrates an improved approach to synthesizing these complex compounds, which are essential in the pharmaceutical industry. Additionally, he has developed an improved process for synthesizing a specific compound—6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-D3)pyridazine-3-carboxamide. This compound is currently undergoing clinical trials for the treatment of auto-immune and auto-inflammatory diseases, such as psoriasis.

Career Highlights

Sergei Kolotuchin has built his career at Bristol-Myers Squibb Company, where he has contributed to groundbreaking research and development in therapeutics. His invention of novel compounds has positioned him as a key player in creating therapies that have the potential to improve patient outcomes.

Collaborations

Throughout his career, Kolotuchin has collaborated with notable colleagues, including Jianji Wang and Truc Chi Vu. These collaborations have facilitated innovative research and development, further enhancing the impact of their collective work on the pharmaceutical landscape.

Conclusion

In summary, Sergei Kolotuchin's contributions to the field of pharmaceuticals through his innovative patents and collaborations at Bristol-Myers Squibb Company highlight his commitment to improving healthcare. With his ongoing research and development efforts, Kolotuchin continues to pave the way for novel therapeutics that address important medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…